Westaim biomedical subsidiary moves to US

Guest Contributor
November 13, 2001

Westaim Corp subsidiary, NUCRYST Pharmaceuticals Corp (formerly Westaim Biomedical Corp), has moved its headquarters and R&D laboratories to Wakefield MA. It has also announced its intention to pursue opportunities for its silver nanocrystalline technology, the only nanotechnology of its type for healthcare applications. The decision to relocate follows successful trials and commercialization of its Acticoat-branded antimicrobial dressings. Acticoat has generated sales of US$15 million since its introduction in 1998. Westain’s corporate headquarters remain in Calgary....

Other News

Events For Leaders in
Science, Tech, Innovation, and Policy

Discuss and learn from those in the know at our virtual and in-person events.

See Upcoming Events

You have 1 free article remaining.
Don't miss out - start your free trial today.

Start your FREE trial    Already a member? Log in


By using this website, you agree to our use of cookies. We use cookies to provide you with a great experience and to help our website run effectively in accordance with our Privacy Policy and Terms of Service.